In future studies, the roles and regulatory mechanisms of POSTN, TRPA1, and DDIT4, which are hub proteins of MSCs, in the progression of NSCLC should be confirmed, and new inhibitors should be developed to delay the progression of NSCLC and improve the prognosis of NSCLC patients. The gene discussed is TRPA1; the disease is non-small cell lung carcinoma.